These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 10727032)
1. Dehydroepiandrosterone-sulfate (DHEA-S) restores the release of IGF-I from natural killer (NK) immune in old patients with dementia of Alzheimer's type (DAT). Solerte SB; Gornati R; Cravello L; Albertelli N; Oberti S; Perotta D; Rossi G; Cuzzoni G; Ferrari E; Fioravanti M J Endocrinol Invest; 1999; 22(10 Suppl):32-4. PubMed ID: 10727032 [No Abstract] [Full Text] [Related]
2. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. Solerte SB; Fioravanti M; Vignati G; Giustina A; Cravello L; Ferrari E J Clin Endocrinol Metab; 1999 Sep; 84(9):3260-7. PubMed ID: 10487697 [TBL] [Abstract][Full Text] [Related]
3. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate. Solerte SB; Ferrari E; Cuzzoni G; Locatelli E; Giustina A; Zamboni M; Schifino N; Rondanelli M; Gazzaruso C; Fioravanti M Dement Geriatr Cogn Disord; 2005; 19(1):1-10. PubMed ID: 15383738 [TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects. Bo M; Massaia M; Zannella P; Cappa G; Ferrario E; Rainero I; Arvat E; Giordano R; Molaschi M Int J Geriatr Psychiatry; 2006 Nov; 21(11):1065-70. PubMed ID: 16977674 [TBL] [Abstract][Full Text] [Related]
5. Impairment of secretory pattern of IGF-I from lymphomononuclear cells in aging and dementia of the Alzheimer's and vascular type. Solerte SB; Cerutti N; Mirani M; Ceresini G; Giusti A; Ferrari E; Fioravanti M J Endocrinol Invest; 2002; 25(10 Suppl):47-50. PubMed ID: 12508915 [No Abstract] [Full Text] [Related]
6. DHEA(S): the fountain of youth. Leowattana W J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S605-12. PubMed ID: 11853289 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects? Carro E; Torres-Aleman I Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618 [TBL] [Abstract][Full Text] [Related]
8. Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): implications in the pathogenesis of Alzheimer's disease. Sinha M; Saha A; Basu S; Pal K; Chakrabarti S Neurosci Lett; 2010 Oct; 483(2):123-6. PubMed ID: 20691758 [TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type. Solerte SB; Fioravanti M; Schifino N; Cuzzoni G; Fontana I; Vignati G; Govoni S; Ferrari E Dement Geriatr Cogn Disord; 1999; 10(1):21-7. PubMed ID: 9844034 [TBL] [Abstract][Full Text] [Related]
10. The nutritional status has no major role in the age-related reduction of IGF-I secretion. Baffoni C; Benso A; Broglio F; Tassone F; Bellone S; Corneli G; Rovere S; Origlia C; Aimaretti G J Endocrinol Invest; 2002; 25(10 Suppl):53-4. PubMed ID: 12508917 [No Abstract] [Full Text] [Related]
11. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Yen SS Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8167-9. PubMed ID: 11459947 [No Abstract] [Full Text] [Related]
13. Dehydroepiandrosterone sulfate and growth axis hormones in patients after surgery. Osorio A; Vara-Thorbeck R; Rosell J; Osorio C; Ortega E; Ruiz-Requena E World J Surg; 2002 Sep; 26(9):1079-82. PubMed ID: 12181608 [TBL] [Abstract][Full Text] [Related]
14. [Neuropsychic effects of dehydroepiandrosterone]. Rigaud AS; Pellerin J Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS43-9. PubMed ID: 11435994 [TBL] [Abstract][Full Text] [Related]
15. The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease. Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Mersich N; Huber ER; Geyer G; Tragl KH Exp Gerontol; 2005 Mar; 40(3):157-63. PubMed ID: 15763392 [TBL] [Abstract][Full Text] [Related]
16. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease? Carro E; Trejo JL; Spuch C; Bohl D; Heard JM; Torres-Aleman I Neurobiol Aging; 2006 Nov; 27(11):1618-31. PubMed ID: 16274856 [TBL] [Abstract][Full Text] [Related]
17. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia. Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175 [TBL] [Abstract][Full Text] [Related]
18. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS. Maes M; Mihaylova I; De Ruyter M Neuro Endocrinol Lett; 2005 Oct; 26(5):487-92. PubMed ID: 16264414 [TBL] [Abstract][Full Text] [Related]
19. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia. Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955 [TBL] [Abstract][Full Text] [Related]
20. The correlations between endogenous dehydroepiandrosterone sulfate and some atherosclerosis risk factors in premenopausal women. Bednarek-Tupikowska G; Tworowska-Bardzińska U; Tupikowski K; Bohdanowicz-Pawlak A; Szymczak J; Kubicka E; Skoczyńska A; Milewicz A Med Sci Monit; 2008 Jan; 14(1):CR37-41. PubMed ID: 18160943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]